T. Rowe Price Associates’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.59M Buy
69,675
+12,231
+21% +$289K ﹤0.01% 1938
2025
Q4
$1.53M Buy
57,444
+2,535
+5% +$74.9K ﹤0.01% 1881
2025
Q3
$1.67M Buy
54,909
+6,951
+14% +$211K ﹤0.01% 1815
2025
Q2
$1.5M Buy
47,958
+8,582
+22% +$284K ﹤0.01% 1780
2025
Q1
$1.5M Buy
39,376
+626
+2% +$26.6K ﹤0.01% 1746
2024
Q4
$1.7M Sell
38,750
-214,003
-85% -$9.4M ﹤0.01% 1723
2024
Q3
$10.9M Sell
252,753
-118,395
-32% -$5.28M ﹤0.01% 1125
2024
Q2
$16.8M Sell
371,148
-9,970
-3% -$517K ﹤0.01% 1000
2024
Q1
$23.8M Buy
381,118
+179,276
+89% +$10.7M ﹤0.01% 935
2023
Q4
$11.3M Buy
201,842
+172,468
+587% +$8.6M ﹤0.01% 1072
2023
Q3
$1.55M Buy
29,374
+2,344
+9% +$137K ﹤0.01% 1578
2023
Q2
$1.73M Sell
27,030
-3,847
-12% -$219K ﹤0.01% 1537
2023
Q1
$1.65M Sell
30,877
-11,363
-27% -$658K ﹤0.01% 1537
2022
Q4
$2.26M Buy
42,240
+3,255
+8% +$168K ﹤0.01% 1424
2022
Q3
$1.8M Sell
38,985
-6,019,178
-99% -$326M ﹤0.01% 1501
2022
Q2
$333M Sell
6,058,163
-4,611,720
-43% -$297M 0.04% 354
2022
Q1
$731M Sell
10,669,883
-77,334
-0.7% -$5.51M 0.07% 262
2021
Q4
$850M Buy
10,747,217
+5,482
+0.1% +$459K 0.08% 252
2021
Q3
$849M Buy
10,741,735
+433,238
+4% +$34.8M 0.08% 254
2021
Q2
$813M Buy
10,308,497
+289,939
+3% +$22.2M 0.08% 257
2021
Q1
$755M Buy
10,018,558
+405,222
+4% +$29.7M 0.08% 269
2020
Q4
$633M Sell
9,613,336
-31,202
-0.3% -$1.82M 0.06% 284
2020
Q3
$521M Buy
9,644,538
+43,541
+0.5% +$2.39M 0.06% 295
2020
Q2
$461M Sell
9,600,997
-20,809
-0.2% -$919K 0.06% 307
2020
Q1
$328M Sell
9,621,806
-3,501
-0% -$192K 0.05% 325
2019
Q4
$603M Sell
9,625,307
-2,862,076
-23% -$162M 0.08% 269
2019
Q3
$625M Buy
12,487,383
+561,143
+5% +$26.5M 0.09% 244
2019
Q2
$575M Buy
11,926,240
+3,217,431
+37% +$155M 0.08% 262
2019
Q1
$445M Buy
8,708,809
+581,353
+7% +$25.5M 0.07% 289
2018
Q4
$292M Buy
8,127,456
+1,180,248
+17% +$55.1M 0.05% 336
2018
Q3
$431M Buy
6,947,208
+6,637
+0.1% +$378K 0.06% 301
2018
Q2
$366M Sell
6,940,571
-193,415
-3% -$10.5M 0.06% 330
2018
Q1
$392M Buy
7,133,986
+229,643
+3% +$14.2M 0.06% 308
2017
Q4
$471M Buy
6,904,343
+3,789,055
+122% +$255M 0.08% 268
2017
Q3
$223M Sell
3,115,288
-14,462
-0.5% -$1.01M 0.04% 425
2017
Q2
$212M Buy
3,129,750
+35,481
+1% +$2.42M 0.04% 423
2017
Q1
$209M Buy
3,094,269
+11,570
+0.4% +$771K 0.04% 422
2016
Q4
$191M Sell
3,082,699
-236,665
-7% -$14M 0.04% 429
2016
Q3
$180M Sell
3,319,364
-499,451
-13% -$25.2M 0.04% 454
2016
Q2
$174M Sell
3,818,815
-1,298,283
-25% -$63.4M 0.04% 444
2016
Q1
$252M Sell
5,117,098
-1,051,604
-17% -$44.7M 0.05% 346
2015
Q4
$248M Buy
6,168,702
+1,038,430
+20% +$47.7M 0.05% 345
2015
Q3
$264M Buy
5,130,272
+131,885
+3% +$8.75M 0.06% 349
2015
Q2
$397M Buy
4,998,387
+118,617
+2% +$10M 0.08% 271
2015
Q1
$401M Buy
4,879,770
+483,783
+11% +$40.5M 0.08% 278
2014
Q4
$390M Buy
4,395,987
+1,439,950
+49% +$130M 0.08% 281
2014
Q3
$290M Sell
2,956,037
-536,501
-15% -$60.3M 0.06% 341
2014
Q2
$448M Sell
3,492,538
-1,021,497
-23% -$128M 0.1% 245
2014
Q1
$554M Buy
4,514,035
+1,444,852
+47% +$166M 0.12% 206
2013
Q4
$336M Sell
3,069,183
-32,089
-1% -$3.21M 0.08% 300
2013
Q3
$302M Sell
3,101,272
-149,706
-5% -$13.8M 0.08% 304
2013
Q2
$292M Buy
+3,250,978
New +$268M 0.08% 303

Other funds holding ENOV

T. Rowe Price Associates's ENOV Position: Q1 2026 in Review

T. Rowe Price Associates increased its Enovis (ENOV) stake by 21% in Q1 2026, buying an estimated $289K and bringing the position to 69,675 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1938.

T. Rowe Price Associates first reported a position in ENOV in Q2 2013 and has held it in 52 quarters since. The position peaked at $850M in Q4 2021. 254 funds tracked by Wall St. Rank hold ENOV as of Q1 2026.

  • T. Rowe Price Associates held 69,675 shares of Enovis worth $1.59M as of Q1 2026.
  • T. Rowe Price Associates bought 12,231 Enovis shares in Q1 2026, an estimated $289K.
  • Enovis made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1938 holding.
  • T. Rowe Price Associates first reported a position in Enovis in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Enovis position peaked at $850M in Q4 2021.
  • 254 funds tracked by Wall St. Rank held Enovis as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.